CYTOSORB THERAPY REGAIN CONTROL Trademark

Trademark Overview

On Thursday, April 4, 2019, a trademark application was filed for CYTOSORB THERAPY REGAIN CONTROL with the United States Patent and Trademark Office. The USPTO has given the CYTOSORB THERAPY REGAIN CONTROL trademark a serial number of 88371010. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by CYTOSORBENTS CORPORATION. The CYTOSORB THERAPY REGAIN CONTROL trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, adsorption and absorption materials and systems for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome SIRS, sepsis and infection, other immunologic conditions, or organ dysfunction or failure
cytosorb therapy regain control

General Information

Serial Number88371010
Word MarkCYTOSORB THERAPY REGAIN CONTROL
Filing DateThursday, April 4, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Goods and ServicesMedical devices, namely, adsorption and absorption materials and systems for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome SIRS, sepsis and infection, other immunologic conditions, or organ dysfunction or failure
Disclaimer with Predetermined Text"THERAPY"

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, April 21, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCYTOSORBENTS CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameCYTOSORBENTS CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Trademark Events

Event DateEvent Description
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 29, 2022SOU EXTENSION 5 GRANTED
Friday, September 16, 2022SOU EXTENSION 5 FILED
Thursday, September 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 16, 2022TEAS EXTENSION RECEIVED
Wednesday, July 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 17, 2022SOU EXTENSION 4 GRANTED
Thursday, March 17, 2022SOU EXTENSION 4 FILED
Thursday, March 17, 2022TEAS EXTENSION RECEIVED
Tuesday, September 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 17, 2021SOU EXTENSION 3 GRANTED
Friday, September 17, 2021SOU EXTENSION 3 FILED
Friday, September 17, 2021TEAS EXTENSION RECEIVED
Friday, March 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 17, 2021SOU EXTENSION 2 GRANTED
Wednesday, March 17, 2021SOU EXTENSION 2 FILED
Wednesday, March 17, 2021TEAS EXTENSION RECEIVED
Saturday, September 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2020SOU EXTENSION 1 GRANTED
Thursday, September 17, 2020SOU EXTENSION 1 FILED
Thursday, September 17, 2020TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 19, 2019ASSIGNED TO LIE
Tuesday, December 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION WRITTEN
Saturday, June 15, 2019ASSIGNED TO EXAMINER
Sunday, April 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2019NEW APPLICATION ENTERED

Related Keywords

control regain therapy cytosorb conditions syndrome sirs response inflammatory systemic sepsis infection dysfunction failure